Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?

Area of Science:

• Pediatric Rheumatology
• Pulmonology
• Immunology

Background:

• Systemic connective tissue diseases (CTDs) are rare in children but frequently involve multiple organs and autoantibodies.
• Pulmonary complications in pediatric CTDs are associated with significant morbidity and mortality.
• The pathophysiology of pleuropulmonary manifestations in CTD remains incompletely understood.

Purpose of the Study:

• To review the clinical spectrum of pleuropulmonary complications in pediatric CTDs.
• To outline current approaches for screening, diagnosis, and monitoring of lung involvement in these conditions.
• To discuss treatment strategies and factors influencing outcomes in pediatric CTD-associated lung disease.

Main Methods:

• Review of common pediatric CTDs including juvenile systemic lupus erythematosus, juvenile dermatomyositis, juvenile systemic sclerosis, Sjögren's syndrome, and mixed connective tissue disease.
• Description of clinical features of pleuropulmonary complications.
• Discussion of diagnostic and monitoring strategies, including imaging and pulmonary function tests.
• Analysis of treatment interventions and their impact on lung disease outcomes.

Main Results:

• Pleuropulmonary complications in pediatric CTDs are diverse and challenging to diagnose and manage.
• Common CTDs discussed include JLE, JDM, JSS, SS, and MCTD.
• Effective management requires a multidisciplinary approach involving pediatric rheumatologists, pulmonologists, and radiologists.

Conclusions:

• Prompt identification and management of pulmonary complications in pediatric CTDs are essential.
• A collaborative, multidisciplinary team approach is paramount for optimizing patient outcomes.
• Further research into the pathophysiology may lead to improved therapeutic strategies.